Posted on September 30, 2009 by Christopher Little
Here’s a look at an email we got from GS1 Healthcare US about the upcoming UDI Conference being held October 20-21, 2009, in Orlando, Florida. It says attendees can expect to receive first-hand information on the progress and direction of the Food and Drug Administration’s (FDA) Unique Device Identification (UDI) draft regulation at this [...]
Filed under: FDA related, GS1, GS1 Adoption, Global Standards | 1 Comment »
Posted on September 29, 2009 by Christopher Little
Big news: In an email today from John Roberts, Director, GS1 Healthcare US, we’re being informed that at a recent seminar in China conducted by AdvaMed, which is a major association of advanced medical technology producers, officials representing the China State Food and Drug Administration (SFDA) said they plan to follow the
Filed under: C-Level Issues, FDA related, GS1, GS1 Adoption, Track & Trace | Leave a Comment »
Posted on September 29, 2009 by Christopher Little
In an online story from the UK’s Financial Times, writer Marko Dimitrijevic says this: The term emerging markets is obsolete. They represent half of the world’s economy; their financial markets are large and liquid, with volatility, corporate governance and government policies very similar to those of developed markets. The traditional distinctions between emerging and developed markets, once [...]
Filed under: C-Level Issues, Emerging Markets Labeling, FDA related, GS1 | Leave a Comment »
Posted on September 28, 2009 by Christopher Little
I’ll be at the upcoming Oracle OpenWorld event starting October 12th in San Francisco. Loftware will have a booth (3108) and I will be participating on an important panel with Oracle, the FDA and GS1 that will spotlight healthcare applications with a special emphasis on supply chain safety and standards.
Filed under: GS1, Hospital, Miscellaneous | Leave a Comment »
Posted on September 28, 2009 by svigneault
This news came over the wire via the Associated Press (AP) at 3:33am this morning:
Filed under: Emerging Markets Labeling, GS1 | Leave a Comment »
Posted on September 27, 2009 by sterling1
Brazil is the “B” in the shorthand for emerging markets sometimes lumped together as BRIC. Quite often here we’ve been covered news for two simultaneous points: emerging markets offer tremendous growth opportunities during this period of economic malaise in developed countries and, two, these emerging markets are making important contributions to the adoption and enforcement [...]
Filed under: C-Level Issues, Emerging Markets Labeling, GS1 | Leave a Comment »
Posted on September 26, 2009 by sterling1
The GS1 Standards Development Event Autumn
Filed under: GS1 | Leave a Comment »
Posted on September 26, 2009 by sterling1
Previously here we commented on the bright future for focuing on emerging markets (and the requisite emerging markets label requirements, largely consisting of . . . GS1 compliance).
Filed under: Emerging Markets Labeling, GS1 | Leave a Comment »
Posted on September 22, 2009 by Christopher Little
Editor’s note: As an editorial decision since the inception of this blog, I’ve steered away from Loftware promotional posts. The panel session cited above, in my opinion, is news and the fact Loftware is in the middle of it, well, does it lose its news worthiness and become an ad? No, I don’t think so.
Announced [...]
Filed under: C-Level Issues, FDA related, GS1, GS1 Adoption, Global Standards, Miscellaneous | 2 Comments »
Posted on September 21, 2009 by sterling1
You probably know that Merck & Co., Inc. and Schering-Plough are merging. But as of today, we now know more about the direction of the combined entities. According to Richard T. Clark, who is chairman, president and chief executive officer of the ‘new’ Merck, the company will look at three key areas for growth as [...]
Filed under: Emerging Markets Labeling, GS1 | Leave a Comment »
Posted on September 20, 2009 by Christopher Little
At this link you can sign up to be on a mailing list which will alert you to a report scheduled for release this fall from GS1 Healthcare US on progress being made to implement GS1’s Global Data Synchronization Network® (GDSN®) in U.S. healthcare supply chains.
Filed under: GS1, GS1 Adoption | Leave a Comment »
Posted on September 19, 2009 by sterling1
David Pogue of The New York Times has written this interesting and positive story entitled, “Charting a New Course,”
Filed under: Hospital, Miscellaneous | Leave a Comment »
Posted on September 18, 2009 by Christopher Little
Harold L. Sirkin is a Chicago-based senior partner of The Boston Consulting Group and author, with James W. Hemerling and Arindam K. Bhattacharya, of GLOBALITY: Competing with Everyone from Everywhere for Everything.
In a recent BusinessWeek viewpoint he summarized why he thinks history will show that these current economic times spurred a tremendous era of globalization,
Filed under: Emerging Markets Labeling, GS1 | Leave a Comment »
Posted on September 17, 2009 by sterling1
This news was issued just yesterday by GS1 out of Brussels, Belgium. As you may know from previous posts here about GS1 MobileCom and its various workgroups, handbooks and white papers, it is a cross-industry initiative involving over one hundred companies seeking agreement on open standards that ensure interoperable, scalable and cost-effective mobile applications.
Filed under: GS1, GS1 Adoption, Global Standards | Leave a Comment »
Posted on September 16, 2009 by Christopher Little
In a news release today, the Premier Healthcare Alliance, which represents more than 2,200 U.S. hospitals and 63,000-plus other healthcare sites, announced upcoming presentations its senior executives will be making around the country in the coming days and months. Premier, you’ll recall, was the first group purchasing organization to endorse the use of GS1 supply [...]
Filed under: C-Level Issues, GS1, Global Standards, HL7 | Leave a Comment »
Posted on September 15, 2009 by sterling1
I should have caught this in July when FDA NEWS posted this update from Jay Crowley, who is the Food and Drug Administration’s senior adviser for patient safety:
Filed under: FDA related, GS1 | 1 Comment »
Posted on September 12, 2009 by sterling1
A company called Amalfi Semiconductor, which is based in Los Gatos, California,
Filed under: Emerging Markets Labeling, GS1 | Leave a Comment »
Posted on September 11, 2009 by Christopher Little
The headline on this Wall Street Journal article not only says it all, but validates the emerging markets focus we’ve been featuring here for months.
Filed under: C-Level Issues, Emerging Markets Labeling, GS1 | Leave a Comment »
Posted on September 9, 2009 by Christopher Little
Thanks to a timely and informative email today from GS1 Healthcare US President Dennis Harrison, we can confirm that the new online Healthcare Supplier Tool Kit developed by the Location Identification, Product Identification and GDSN Implementation workgroups is being launched.
Filed under: GS1 | Leave a Comment »
Posted on September 9, 2009 by svigneault
The Food and Drug Administration on Tuesday unveiled a new electronic database where manufacturers must notify the government if they believe one of their products is likely to cause sickness or death in people or animals.
Filed under: FDA related, GS1, Patient safety | Leave a Comment »